Systems BiologyAntimicrobial Agents and ChemotherapyPeer-reviewed
Plasma nirmatrelvir and molnupiravir concentrations required for inhibition of SARS CoV-2 replication differ between rhesus macaques and humans
Ugo Avila-Ponce de León, Shadisadat Esmaeili, Katherine L. Owens, Joshua Tisdell Schiffer
The paper models drug efficacy in rhesus macaques and humans to show differences in required plasma concentrations for antiviral activity against SARS-CoV-2.
1 citationtop 4%